Search
並前往 https://www.businesswire.com/news/home/20230227005266/en/Establishment-Labs-Submits-Module-Four-to-U.S.-FDA-for-Premarket-Approval-of-Motiva-and-Reports-Record-Fourth-Quarter-and-Full-Year-2022-Financial-Results
是否確定要離開?
確定! 回上一頁